| |
| | [No title] (Site not responding. Last check: 2007-10-30) |
 | | The goal of these studies is to define the pathogenetic and pathophysiological processes that give rise to the cognitive deficits of schizophrenia and to identify potential targets for novel therapeutic interventions. |
 | | Cruz, D.A., Eggan, S.M., and Lewis, D.A.: Postnatal development of pre- and post-synaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. |
 | | Lewis, D.A., Volk, D.W., and Hashimoto, T.: Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: A novel target for the treatment of working memory dysfunction. |
| cnup.neurobio.pitt.edu /alphafac_details.cfm?id=40 (487 words) |
|